Figures & data
Figure 1 Minimum inhibitory concentration of free ciprofloxacin and ciprofloxacin-loaded niosomal preparations against tested S. aureus strains.
![Figure 1 Minimum inhibitory concentration of free ciprofloxacin and ciprofloxacin-loaded niosomal preparations against tested S. aureus strains.](/cms/asset/f221af25-c21b-43d8-8cdd-7b7895998cef/didr_a_249628_f0001_b.jpg)
Figure 2 Characterization of the prepared ciprofloxacin-loaded niosomes using dynamic light scattering technique. (A) Size distribution histogram, (B) zeta potential distribution.
![Figure 2 Characterization of the prepared ciprofloxacin-loaded niosomes using dynamic light scattering technique. (A) Size distribution histogram, (B) zeta potential distribution.](/cms/asset/743de532-4177-4e19-82b8-6088332b716a/didr_a_249628_f0002_c.jpg)
Table 1 Minimum Biofilm Inhibitory Concentration and Minimum Biofilm Eradication Concentration of Free Ciprofloxacin Solution and Ciprofloxacin-Loaded Noisomal Preparation II against S. aureus Isolates
Figure 3 Visualization of S. aureus biofilms formed in the presence of subinhibitory concentration of free ciprofloxacin and ciprofloxacin-loaded niosomes, using an electron microscope. (A) Untreated culture (positive control), (B) culture in the presence of 1/8 MIC of ciprofloxacin, (C) culture in the presence of 1/8 MIC of ciprofloxacin-loaded niosomes.
![Figure 3 Visualization of S. aureus biofilms formed in the presence of subinhibitory concentration of free ciprofloxacin and ciprofloxacin-loaded niosomes, using an electron microscope. (A) Untreated culture (positive control), (B) culture in the presence of 1/8 MIC of ciprofloxacin, (C) culture in the presence of 1/8 MIC of ciprofloxacin-loaded niosomes.](/cms/asset/e3add138-2ecc-4183-849d-47b930952ee3/didr_a_249628_f0003_b.jpg)